In this session, Pall Corporation and Evello International will share their best practices on how to optimize your extraction and filtration process.
A key step in cannabis oil production is the decarboxylation of naturally produced THCA to psychotropic THC or CBDA to CBD, respectively.
In this presentation, Morgan Boyle, Lead Microbiologist and Cannabis Science Consultant will discuss the current status of microbial testing requirements and the need for testing standardization throughout the U.S.
Speaking at the Analytical Cannabis Expo West Online 2021 in April, Dr Emily Britton, Senior Marketing Manager for Food & Natural Products at Waters presented her talk outlining a solution for the quantitation of 18 cannabinoids in various cannabis and derived edible products using UPLC with UV and mass detection.
Speaking back in April at the Analytical Cannabis Expo West Online 2021, Dr Toby Astill, Senior Business Development Leader for Cannabis & Hemp Markets at PerkinElmer presented an innovative simplified workflow for pesticide and mycotoxin residue analysis in cannabis and hemp.
Speaking at the Analytical Cannabis Expo West Online 2021 in April, Wallace Harvey, Regional Business Manager – Lab Weighing at Sartorius presented his research study comparing the classical oven (loss-on-drying) method with an infrared method, with regard to analysis times and result precision as a function of both sample quantity and initial moisture content.
Atomic Absorption Spectroscopy (AAS) is an inexpensive and mature elemental analysis technique used in thousands of laboratories. Food laboratories use AAS to analyze a diverse range of foods for nutritional and/or safety purposes.
During this webinar, Alisia Ratliff, CEO, Victus Capital Ventures, will discuss the history of extraction and what became prominent in the industry, the most common methodologies of extraction currently used and the technical developments of each, and the future of cannabis extraction and innovative technologies.
In this presentation, Cosmo Feilding-Mellen, co-founder and chief executive of Oxford-based psychedelic medicine company Beckley Psytech will take stock of the current psychedelic innovation landscape and the vast potential for psychedelic treatments in healthcare.
Join Dr Natalia Sannikova and Tomas Skrinskas from Ascension Sciences, as they explore the therapeutic use of cannabinoids as novel medicines and the opportunities of nanotechnology in formulating cannabinoid nanoparticles.